2 results
Approved WMORecruiting
This study has been transitioned to CTIS with ID 2023-509380-24-00 check the CTIS register for the current data. The purpose of this study is to investigate the effect of treatment with two courses of chemotherapy followed by immunotherapy. Immune…
Approved WMORecruiting
This first-in-man study will investigate the safety and tolerability as well as establish a recommended dose of INCB081776 as a monotherapy (Part 1) and then in combination with INCMGA00012 (Part 2) in participants with advanced malignancies. During…